Navigation mit Access Keys

Main Content

Main Content

News

October 13, 2020

SNSF Eccellenza Assistant Professor

The Biozentrum of the University of Basel is looking to sponsor applicants for Eccellenza Professorial Fellowships from the Swiss National Science...

September 22, 2020

Apply now! Biozentrum PhD Fellowships

With its prestigious and much sought after PhD Fellowships, the Biozentrum enables ambitious and highly motivated young scientists to do their PhD at...

September 09, 2020

Muscle aging: Stronger for longer

With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging. Researchers...

September 03, 2020

Maria Hondele awarded ERC Starting Grant

Prof. Maria Hondele from the Biozentrum of the University of Basel has been awarded one of the highly coveted Starting Grants by the European Research...

August 25, 2020

Two new Professors appointed to the Biozentrum

Prof. Knut Drescher and Anissa Kempf have been appointed new Professors by the Biozentrum of the University of Basel. Knut Drescher studies the...

August 19, 2020

Breast cancer: New way for tumor cells to escape self-destruction

In the body, the so-called programmed cell death prevents cells with irreparable damage from surviving and turning into cancer cells. In the “EMBO...

August 05, 2020

Autism: How gene alteration modifies social behavior

Prof. Peter Scheiffele’s team at the Biozentrum, University of Basel, has discovered a new connection between a genetic modification and social...

July 22, 2020

T3 Pharma: Bacterial cancer treatment on the path to enter clinical phase

The Basel-based biotech company and Biozentrum spin-off T3 Pharmaceuticals AG is breaking new ground in the treatment of cancer by using live...

July 07, 2020

Fiona Doetsch newly elected EMBO member

Prof. Fiona Doetsch from the Biozentrum of the University of Basel has been elected as a new member of the prestigious European Molecular Biology...

June 22, 2020

Biozentrum spin-off ARTIDIS announces successful clinical trial

The company ARTIDIS announced that its nanotechnology platform is able to detect breast cancer with a high sensitivity. This has been shown in the...